BMC Pregnancy and Childbirth,
Journal Year:
2025,
Volume and Issue:
25(1)
Published: March 13, 2025
Polyfluoroalkyl
and
perfluoroalkyl
substances
(PFAS)
are
persistent
organic
pollutants
exposure
have
been
suggested
with
the
risk
of
developing
preeclampsia.
Yet,
evidence
on
associations
PFAS
preeclampsia
is
still
conflicting.
Thus,
current
study
conducted
a
systematic
review
meta-analysis
epidemiological
linking
maternal
to
This
research
methodology
involved
searching
three
electronic
databases
for
studies,
then
conducting
using
random-effects
model
analyse
heterogeneity
between
studies.
The
quality
strength
each
exposure-outcome
pair
was
also
evaluated,
as
well
bias.
search
identified
10
potentially
eligible
studies
related
blood
level
preeclampsia,
which
7
were
ultimately
selected.
Meta-analysis
demonstrated
association
combined
compounds
in
pregnant
mother
zero
(I2=0.0%,
Q=
3.09,
df=
6,
p=0.798).
Preeclampsia
found
moderate
perfluorooctanoic
acid
(PFOA)
(Test
overall
effect:
z=2.2,
p=0.03;
Test
heterogeneity:
I2=0.0%,
3.49,
p=0.745)
perfluorooctane
sulfonate
(PFOS)
z=2.5,
p=0.01;
3.70,
p=0.718).
showed
significant
PFOA
PFOS
However,
in-depth
investigation
imperative
elucidate
impact
different
concentration
types
risk.
Eco-Environment & Health,
Journal Year:
2024,
Volume and Issue:
3(4), P. 476 - 493
Published: Aug. 30, 2024
Per-
and
polyfluoroalkyl
substances
(PFAS)
are
endocrine
disruptors
with
unambiguous
neurotoxic
effects.
However,
due
to
variability
in
experimental
models,
population
characteristics,
molecular
endpoints,
the
elucidation
of
mechanisms
underlying
PFAS-induced
neurotoxicity
remains
incomplete.
In
this
review,
we
utilized
adverse
outcome
pathway
(AOP)
framework,
a
comprehensive
tool
for
evaluating
toxicity
across
multiple
biological
levels
(molecular,
cellular,
tissue
organ,
individual,
population),
elucidate
induced
by
PFAS.
Based
on
271
studies,
reactive
oxygen
species
(ROS)
generation
emerged
as
initiating
event
1
(MIE1).
Subsequent
key
events
(KEs)
at
cellular
level
include
oxidative
stress,
neuroinflammation,
apoptosis,
altered
Ca
Journal of Environmental Science and Health Part C,
Journal Year:
2025,
Volume and Issue:
unknown, P. 1 - 25
Published: Feb. 20, 2025
Poly-
and
per-fluoroalkyl
substances
(PFAS)
are
a
large
group
of
synthetic
compounds
having
wide
array
use
in
consumer
products
industries,
such
as
fire
suppressant
foam,
nonstick
cookware,
paper,
water-proof
textiles,
surfactants,
aeronautics,
cosmetics.
This
widespread
distribution
PFAS,
their
capacity
to
accumulate
living
organisms,
harmful
effects
represent
rising
concern
for
public
health.
A
multitude
studies
have
presented
information
on
exposure
PFAS
broad
spectrum
adverse
health
outcomes
through
animal
models
observational
studies.
Here,
we
reviewed
various
that
related
toxicity
bone
brain
its
underlying
mechanisms.
well-established
toxicological
bone,
reduced
osteoblastic
increased
osteoclastic
activity,
activation
peroxisome
proliferator
activated
receptor-γ
(PPAR-γ),
expression
WNT11.
With
respect
brain,
been
linked
with
autism,
somnolence,
sleep
disturbances,
glioma,
Alzheimer's,
decreased
cognition,
Glycogen
Synthase
β
(GSK3β).
Further
research
is
required
several
areas,
age-specific
impact
other
beyond
perfluorooctane
sulfonate
(PFOS)
perfluorooctanoic
acid
(PFOA),
involvement
proliferator-activated
receptors
PFAS-induced
toxicity.
Regarding
toxicity,
extensive
adults
there
currently
relative
scarcity
this
age
when
compared
the
available
conducted
children
older
individuals.
The Science of The Total Environment,
Journal Year:
2025,
Volume and Issue:
969, P. 178972 - 178972
Published: Feb. 28, 2025
While
emerging
evidence
links
per-
and
polyfluoroalkyl
substances
(PFAS)
to
neurotoxicity,
their
potential
role
in
neurodegeneration
remains
poorly
understood.
Moreover,
existing
neurodegeneration-related
adverse
outcome
pathways
(AOPs)
available
on
AOP-Wiki
have
not
yet
been
integrated
into
a
unified
network.
To
address
these
gaps,
this
study
aims
develop
the
first
AOP
network
utilize
it
explore
possible
contributions
of
long-chain
legacy
PFAS
neurodegeneration,
specifically
concerning
Alzheimer's
Parkinson's
diseases.
A
total
74
AOPs
were
screened
from
AOP-Wiki,
which
13
met
eligibility
criteria
incorporated
We
analyzed
resulting
using
topological
parameters
such
as
in-degree,
out-degree,
eccentricity,
betweenness
centrality.
elucidate
mechanistic
exposure
neurodegenerative
pathways,
we
linking
key
events
(KEs)
within
The
results
highlighted
increased
intracellular
calcium
hub
with
highest
connectivity
followed
by
critical
KEs
neuronal
apoptosis,
oxidative
stress,
N-methyl-d-aspartate
receptor
(NMDA-R)
overactivation,
mitochondrial
dysfunction.
Consistent
toxicological
evidence,
indicate
that
may
adversely
affect
neurotransmitter
systems,
particularly
through
NMDA-R
leading
excitotoxicity.
This
result
dyshomeostasis,
dysfunction,
inflammatory-oxidative
cascades,
neuroinflammation,
cell
death.
By
providing
basis
for
understanding
PFAS,
offers
crucial
framework
assessing
risks
associated
chemicals
inform
future
regulatory
measures
public
health
strategies.
Further
experimental
validation
is
needed
confirm
animal
models
or
human
populations.
BMC Pregnancy and Childbirth,
Journal Year:
2025,
Volume and Issue:
25(1)
Published: March 13, 2025
Polyfluoroalkyl
and
perfluoroalkyl
substances
(PFAS)
are
persistent
organic
pollutants
exposure
have
been
suggested
with
the
risk
of
developing
preeclampsia.
Yet,
evidence
on
associations
PFAS
preeclampsia
is
still
conflicting.
Thus,
current
study
conducted
a
systematic
review
meta-analysis
epidemiological
linking
maternal
to
This
research
methodology
involved
searching
three
electronic
databases
for
studies,
then
conducting
using
random-effects
model
analyse
heterogeneity
between
studies.
The
quality
strength
each
exposure-outcome
pair
was
also
evaluated,
as
well
bias.
search
identified
10
potentially
eligible
studies
related
blood
level
preeclampsia,
which
7
were
ultimately
selected.
Meta-analysis
demonstrated
association
combined
compounds
in
pregnant
mother
zero
(I2=0.0%,
Q=
3.09,
df=
6,
p=0.798).
Preeclampsia
found
moderate
perfluorooctanoic
acid
(PFOA)
(Test
overall
effect:
z=2.2,
p=0.03;
Test
heterogeneity:
I2=0.0%,
3.49,
p=0.745)
perfluorooctane
sulfonate
(PFOS)
z=2.5,
p=0.01;
3.70,
p=0.718).
showed
significant
PFOA
PFOS
However,
in-depth
investigation
imperative
elucidate
impact
different
concentration
types
risk.